Research Article

Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine

Table 4

Laboratory markers in peripheral blood before vaccination.

FactorPPV + JTT
( )
PPV alone
( )
value

Hemoglobin (g/dL) 0.4821
Lymphocyte count (/mm3) 0.8732
Albumin (g/dL) 0.0895
Creatinine (mg/dL) 0.6791
Total bilirubin (mg/dL) 0.7829
IL-2 (pg/mL) 0.3800
IL-4 (pg/mL) 0.3160
IL-5 (pg/mL) 0.8965
IL-6 (pg/mL) 0.5134
IL-10 (pg/mL) 0.3415
IL-12 (pg/mL) 0.5433
IL-18 (pg/mL) 0.9731
IFN- (pg/mL) 0.4495
TGF- 1 (ng/mL) 0.7278
C-reactive protein (mg/dL) 0.2015
Serum amyloid A ( g/mL) 0.1505
d-ROM (U.CARR) 0.2424
BAP ( mol/L) 0.7442

Values are means ± standard deviations.
d-ROM: derivatives of reactive oxidative metabolites: U.CARR, Carratelli unit (1 Carratelli unit = 0.8 mg H2O2/L).
BAP: biological antioxidant potential.